children with CHF associated with rheumatic heart disease and concluded that heart failure in children, as in adults, could often be attributed to mechanical causes, atrial fibrillation, or drug toxicity, rather than to active rheumatic carditis. No further studies on the problem have since been carried out, and it thus seemed desirable to investigate the question in our centre, where there is an ample supply of clinical material.
Materials and methods A series of 418 children suffering from rheumatic heart disease and aged between 6 and 14 years formed the subject of this study. They were divided into two groups: a study group (S) given benzathine penicillin prophylaxis and a control group (C) given injections of sterile water.
The two groups (S and C) were selected on a random basis, carefully matched with regard to age, sex, and severity of cardiac involvement. During the early stages of the study, however, it was thought advisable to transfer twelve young children with severe heart disease from the control to the study group, so that they should receive much-needed therapy. The study group thus numbered 221 and the control group 197 cases.
The study was conducted for 3 years. All patients were encouraged to attend our outpatient clinic regularly, where they underwent periodical clinical and laboratory examination and received monthly injections. Laboratory tests included the determination of the ESR (Wintrobe, 1961) , the blood serum antistreptolysin-O titre (ASOT) (Rantz and Randall, 1945) , and throat swabs for identification of group A beta-haemolytic streptococci. Radiographs of the chest and electrocardiograms were taken yearly and whenever thought desirable.
For the first 18 months the study group received a monthly intramuscular injection of Depot V Biotic, 1,200,000 units. When its potency was assessed it proved to be equivalent to only 900,000 units of benzathine penicillin, and Penadur (1,200,000 units) was therefore used in place of the Depot V for the next 18 months of the study. A urine test for penicillin using the lutea sarcinata cultures (Markowitz and Gordis, 1968) was done from time to time before the next injection of Penadur to ensure a penicillin action althrough the month.
The onset of CHF was carefully noted. Diagnosis was based on classical signs and symptoms, i.e. dyspnoea, palpitations, enlargement of the liver, and raised venous pressure with or without oedema of the lower limbs. Children who developed heart failure were carefully studied with regard to the effect of chemoprophylaxis, and the correlation of CHF with ASOT levels, ESR, and other major and minor criteria of rheumatic activity (Duckett Jones, 1944) .
Results
Tables I and II show the effect of chemoprophylaxis on the incidence of congestive heart failure. The incidence of CHF became lower in the study group than in the control group during the second 18 months, suggesting that CHF may well be related to the occurrence of active rheumatic carditis. The general incidence of CHF declined during the second phase of the investigation, owing perhaps to more regular attendance and early treatment of suspected activity.
Thirty-nine cases with CHF, who had been under close supervision and who had had repeated ASOT determinations for at least 4 months before the onset of heart failure, were analysed with relation to their ASOT levels coincident with or just before the onset of heart failure. The results are shown in Table III . Table IV .
Discussion
Knowledge about the causes of heart failure in these patients is not only of academic interest but also of 18-2 5 15-2 practical importance. Suppressive treatment of an inflammatory lesion in the heart may help to relieve heart failure and may thus contribute to prolonging life. The clinical diagnosis of disease activity is, however, by no means always easy. For many years there was a tendency to accept the onset of CHF in a rheumatic child as evidence of an active rheumatic process in the heart, although proof for this assumption was lacking. Nadas and Hauck (1960) wrote: 'The axiom, the origin of which is hard to trace, is that a child with CHF on a rheumatic basis always has active carditis.' Spagnuolo and Feinstein (1964) questioned this axiom, pointing out that it did not seem to rest on firm evidence. They further concluded that many of the heart failure episodes in rheumatic children are actually mechanical, the result of atrial fibrillation, drug toxicity, etc.
The data obtained in our present study, however, seem to support the older views. Elevation of the ASOT at the onset of an attack of heart failure occurring in 84 per cent. of young children is strongly indicative of a recent streptococcal infection which has presumably brought about active disease in the heart (rheumatic activity) and heart failure.
Though atrial fibrillation (perhaps related in part to digitalis intolerance on the part of the inflamed myocardium) may have contributed to heart failure, careful interrogation of patients yielded a history of arthritis or arthralgia some time before the onset of heart failure, or an elevated ASOT 1 or 2 months previously.
An elevated ESR is difficult to assess among our cases because of the general prevalence of high ESRs among our rheumatic children, even among those with no concomitant active disease (Abdin and Abul-Fadl, 1971 ). Nevertheless, our observations indicate that a major rise in ESR was rather frequent with cases of CHF. However, the ESR was sometimes seen to be quite low at the onset of severe CHF with huge liver enlargement, and was observed to rise later to high levels when the failure improved. We cannot therefore use the level of ESR to exclude, or to confirm, active disease in such cases, especially if the rise is not large (Abdin and Abul-Fadl, 1971) .
In view of our present results we are inclined to consider a recent onset of CHF in a rheumatic child of 13 years or below, who had been free from signs of heart failure for a year or more, as evidence of active carditis, and to treat it on this basis using suppressive antirheumatic treatment. Chronic heart failure can, however, be treated differently, being managed largely with anti-failure measures. Summary In a follow-up study of 418 children with rheumatic heart disease, the incidence of congestive heart failure was lower in a group treated with chemoprophylaxis than in a control group. Over 80 per cent. of cases developing heart failure were shown to have an elevated antistreptolysin-O titre at or shortly before the time of failure. It is concluded that congestive heart failure in these circumstances indicates the presence of active rheumatic carditis and should be treated accordingly.
